Загрузка...
Changing strategies for target therapy in gastric cancer
In spite of a worldwide decrease in the incidence of gastric cancer, this malignancy still remains one of the leading causes of cancer mortality. Great efforts have been made to improve treatment outcomes in patients with metastatic gastric cancer, and the introduction of trastuzumab has greatly imp...
Сохранить в:
| Опубликовано в: : | World J Gastroenterol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Baishideng Publishing Group Inc
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4716029/ https://ncbi.nlm.nih.gov/pubmed/26811656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i3.1179 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|